Companian Diagnostic Technologies 2016 Global Market Opportunities and Forecasts 2022

WiseGuyReports.com adds“Companian Diagnostic Technologies 2016 Global Market Opportunities and Forecasts 2022”reports to its database.

COMPLETE REPORT DETAILS @ https://www.wiseguyreports.com/reports/world-companian-diagnostic-technologies-market-opportunities-and-forecasts-2014-2022

Companion diagnostic is an in-vitro diagnostic process that provides information about therapeutic response of patient for a specific treatment. This tool improves the therapeutic efficiency and decreases healthcare cost. According to PricewaterhouseCooper (PwC) report, the number of pharmaceutical and diagnostic companies has increased from 19 in 2009 to 44 in 2010. Companion diagnostic is a segment of personalized medicine that includes drug-testing, therapies, clinical trials and research. Increase in demand for targeted therapies is attracting pharmaceutical companies to develop low cost and highly efficient drugs. Commercialization of Pfizer’s targeted lung cancer therapeutics and Roche’s personalized therapies indicated the increased value for companion diagnostic market. Companion diagnostic market growth is hindered because of latency in approval of technologies. Companies are taking longer time for approval of drugs and therapies. For Example, Abbott, Pfizer, Bayer, Life Technologies and GSK are facing challenges to receive approval for commercialization from the FDA.

The demand for increased awareness in personalized medicines and cost effective diagnosis is changing the landscape of pharmaceutical companies. Companies engaged in diagnostic research are facing challenges in terms of adoption of novel therapies in healthcare market, and competition for gaining competitive advantages to position their products. This report focuses on recent development happened in companion diagnostic market and its comparative analysis, thereby providing intelligence to companies involved in personalized medicines.

For more information or any query mail at sales@wiseguyreports.com     

The key players included are Assurerx Health, Asuragen Inc., Beckman Coulter Inc., Bg Medicine Inc., Biocrates Life Sciences Ag, Cardiodx, Celera, Dako (Agilent Technologies), Diagnocure Inc., Epigenomics Ag, Foundation Medicine Inc., Genelex Corp., Genmark Diagnostics.

KEY BENEFITS

In depth intelligence of top factors such as drivers, restraints and opportunities influencing companion diagnostic market growth.
Value chain analysis provides flow of therapies and monitoring in various chains of diagnostic segments These segments are analyzed and presented in detail in the report
Therapeutics segment of companion diagnostic market is thoroughly explained with GE9 Cell matrix 

SWOT analysis and strategic developments are included in the report for Key market players to get better understanding of potential opportunities and challenges for companies.
The report provides intelligence on diagnostic technology adoption according to geographies, that assists research institutes to take developmental decision

REQUEST FOR TABLE OF CONTENTS @ https://www.wiseguyreports.com/request-toc/world-companian-diagnostic-technologies-market-opportunities-and-forecasts-2014-2022

KEY MARKET SEGMENTS

BY THERAPEUTICS

Oncology diseases
Breast Cancer
Lung Cancer
Colorectal Cancer
Gastric Cancer
Others 

BY GEOGRAPHY

North America
Europe
Asia-Pacific 

ROW 

KEY AUDIENCES

Pharmaceutical companies
Government regulatory authorities
Research companies
Academic institutes
Have questions ?

RESEARCH METHODOLOGY

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
 

• Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
• Technologically sophisticated and reliable insights through well audited and veracious research methodology
• Sovereign research proceeds that present a tangible depiction of marketplace

CONTINUE…….

PRE-BOOK REPORT @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=512135

For more information or any query mail at sales@wiseguyreports.com

Contact Us:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)